Search

everythinglearnresearchcommunity

for

Search:↓

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

Supplements improve health, appearance, and athletic performance.

New compounds may help treat prostate issues without affecting androgen receptors.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by blocking male sex hormones.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Hormonal treatments effectively treat acne in females and could reduce antibiotic use.

Compound 15a was effective in inhibiting 5α-reductase.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

Some sports supplements can cause health issues like mood swings, hair loss, and heart problems in men.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

Neurosteroids may help treat disorders with too much dopamine activity.

Scientists made two new chemicals that might help treat diseases caused by male hormones.

Monocyclic aromatic compounds are important for developing various drugs and treatments.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

New treatments for male hypogonadism are easier to use and target specific tissues to reduce side effects.

Epitestosterone may act as a weak antiandrogen and can inhibit an enzyme involved in testosterone metabolism.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

The compound 4c effectively inhibits the enzyme linked to hair loss.

Androgenic steroids can slow down or stop the growth of certain skin fungi.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

New curcumin analogues help fight prostate cancer by breaking down androgen receptors.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.